212268-44-5

Basic information

• Product Name: 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE
• Synonyms: 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE
• CAS NO: 212268-44-5
• Molecular Formula: C₁₁H₁₂ClN₃
• Molecular Weight: 221.69
• Mol File: 212268-44-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE(212268-44-5)
• EPA Substance Registry System: 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE(212268-44-5)

Safety Data

• Hazardous Substances Data: 212268-44-5(Hazardous Substances Data)

Usage

General Description

4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE is a chemical compound with the molecular formula C11H10ClN3. It is a chlorinated pyrrolopyrimidine derivative, and its structure consists of a chloro group, a cyclopentyl ring, and a pyrrolopyrimidine ring. 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE has potential applications in pharmaceutical and agrochemical industries due to its biological activities, particularly in the inhibition of specific enzymes or receptors. It has been studied for its potential as an antiviral and anticancer agent, and it may also have applications in the development of novel pesticides. Further research is needed to fully understand and exploit the chemical properties and potential uses of 4-CHLORO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDINE.

Upstream product

• 137-43-9 Cyclopentyl bromide 
• 3680-69-1 4-chloro-1H-pyrrolo[2,3-d]pyrimidine 
• 2049-80-1 (2-propenyl)propanedioic acid diethyl ester 
• 96-41-3 Cyclopentanol 
• 16019-31-1 5-allyl-4,6-dichloropyrimidine 
• 16019-30-0 5-allyl-6-hydroxy-3H-pyrimidin-4-one 
• 1003-03-8 Cyclopentamine 
• 16019-33-3 2-(4,6-dichloropyrimidin-5-yl)acetaldehyde 
• 186519-89-1 7-(benzenesulfonyl)-4-chloro-7H-pyrrolo[2,3-d]pyrimidine 

Downstream Products

• 1398560-55-8 C₁₇H₁₈N₄O 
• 213745-17-6 4-chloro-7-cyclopentyl-5-iodo-7H-pyrrolo[2,3-d]pyrimidine 

Relevant articles and documents

ATROPISOMERISM FOR ENHANCED KINASE INHIBITOR SELECTIVITY

The invention provides a series of conformationally stable and selective kinase inhibitors, and methods of using the kinase inhibitors. The effect of atropisomerism on kinase selectivity was assessed, finding improved selectivity compared to rapidly inter

Exploiting Atropisomerism to Increase the Target Selectivity of Kinase Inhibitors

Many biologically active molecules exist as rapidly interconverting atropisomeric mixtures. Whereas one atropisomer inhibits the desired target, the other can lead to off-target effects. Herein, we study atropisomerism as a possibility to improve the sele

PYRROLOPYRIMIDINE DERIVATIVES

The invention relates to compounds of the formula 1or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein Q, A, L, R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.